Hot Features
Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.
Xilio Therapeutics Inc is a biotechnology company focused on harnessing the immune system to achieve deep and durable clinical responses to improve the lives of patients with cancer. Leveraging the GPS platform, they are building a pipeline of tumor-selective cytokine and checkpoint inhibitor immuno... Xilio Therapeutics Inc is a biotechnology company focused on harnessing the immune system to achieve deep and durable clinical responses to improve the lives of patients with cancer. Leveraging the GPS platform, they are building a pipeline of tumor-selective cytokine and checkpoint inhibitor immunotherapies to treat cancer. The goal is to overcome the limitations of current I-O therapies by developing products with an improved therapeutic index. Mehr anzeigen
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.020613 | -2.64061705352 | 0.780613 | 0.816 | 0.7407 | 244001 | 0.78426786 | CS |
| 4 | -0.1676 | -18.0681328159 | 0.9276 | 1.03 | 0.729 | 581833 | 0.86280128 | CS |
| 12 | -0.1906 | -20.0504944246 | 0.9506 | 1.7 | 0.63 | 4182059 | 1.36741665 | CS |
| 26 | 0.0066 | 0.876028670029 | 0.7534 | 1.7 | 0.63 | 2126147 | 1.3384232 | CS |
| 52 | 0.0575 | 8.18505338078 | 0.7025 | 1.93 | 0.58 | 1413134 | 1.29949543 | CS |
| 156 | -6.55 | -89.6032831737 | 7.31 | 8.0995 | 0.49 | 520585 | 1.37131256 | CS |
| 260 | -14.24 | -94.9333333333 | 15 | 27.95 | 0.49 | 468564 | 1.72846216 | CS |
Die zuletzt besuchten Aktien werden in diesem Feld angezeigt, so dass Sie leicht zu den Aktien zurückkehren können, die Sie zuvor angesehen haben.
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
